3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Glioblastoma
527
Brain Neoplasms
413
Glioma
342
Astrocytoma
239
Central Nervous System Neoplasms
201
Neuroblastoma
195
Gliosarcoma
163
Oligodendroglioma
149
Medulloblastoma
118
Neoplasms
113
Ependymoma
72
Recurrence
70
Breast Neoplasms
69
Sarcoma
65
Melanoma
62
Osteosarcoma
57
Carcinoma, Non-Small-Cell Lung
57
Diffuse Intrinsic Pontine Glioma
48
Wilms Tumor
47
Familial ependymoma
47
Lymphoma
46
Neoplasm Metastasis
45
Optic Nerve Glioma
44
Rhabdomyosarcoma
42
Rhabdoid Tumor
42
Choroid Plexus Neoplasms
42
Lung Neoplasms
41
Neuroectodermal Tumors, Primitive
38
Meningeal Carcinomatosis
38
Ovarian Neoplasms
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Pathologic Processes
×
CNS
×
Clear all
NCT07098806
2025-08-01
CA2024-LM-001
Plus Therapeutics
Phase 1
Recruiting
24 enrolled